JILLIAN CONNER: Open Payments
NPI 1750732335 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 37 payments from 20 companies in 2025. Trend: 2023 $1,298 · 2024 $1,180 · 2025 $830
Food & beverage: $755Education: $75
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $138 |
| Daiichi Sankyo Inc. | 3 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| ABBVIE INC. | 5 | $80 |
| Janssen Biotech, Inc. | 3 | $59 |
| Genmab U.S., Inc. | 2 | $41 |
| Genentech USA, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
Products named: REBLOZYL, Enhertu, Fabhalta, EPKINLY, TALVEY, SCEMBLIX, FRUZAQLA, OPDIVO.
Industry payments across NJ — which companies pay providers there.
